Skip to content

Studying the effect of hyaluronidase in frozen shoulder

Comparing the effectiveness of periarticular hyaluronidase injection with intraarticular corticosteroid injection under ultrasound guidance on pain, function and range of motion in patients with adhesive capsulitis, a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250528065950N1
Enrollment
56
Registered
2025-07-18
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

frozen shoulder or adhesive capsulitis. Adhesive capsulitis of unspecified shoulder

Interventions

Intervention 1: Intervention group 1: Enzyme capsulotomy includes injection of 1500 international units of hyaluronidase enzyme diluted with 5 cc of 0.9% normal saline for injection, around the should
the target points include the rotator interval, along the coracohumeral ligament, and the axillary crease. This injection will not be repeated at subsequent visits
at weeks 4 and 12, the shoulder pain and disability index questionnaire and passive range of motion in the directions of external and internal rotation and abduction will be recorded using a goniomete

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Completing and signing the consent form The presence of pain and other clinical symptoms suggestive of adhesive capsulitis in clinical phase 2. Age between 40-70 years old Absence of any disease in the relevant surroundings joint

Exclusion criteria

Exclusion criteria: Diabetes Rheumatic and collagen vascular diseases like gout and lupus Concomitant radiculopathy Neuropathies Brucella Body mass index above 42 Trauma and fracture of the affected joint History of bleeding diseases Using anticoagulant drugs History of significant liver or kidney or cardiopulmonary disorders History of injections in or around the affected joint in the past 3 months Pregnant women Cancer History of allergies and allergic reactions to the drugs used

Design outcomes

Primary

MeasureTime frame
Pain level. Timepoint: Weeks 4 and 12. Method of measurement: Shoulder Pain And Disability Index (SPADI) questionnaire and use of goniometer.;Function level. Timepoint: Weeks 4 and 12. Method of measurement: Shoulder Pain And Disability Index(SPADI) questionnaire and use of goniometer.;Range of motion (ROM). Timepoint: Weeks 4 and 12. Method of measurement: use of goniometer device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadali Narimani

Shiraz University of Medical Sciences

mohammadali.narimani76@gmail.com+98 71 3646 2245

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026